These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20941956)

  • 1. Cutaneous lupus erythematosus and anti-TNF-alpha therapy: a case report with review of the literature.
    Levine D; Switlyk SA; Gottlieb A
    J Drugs Dermatol; 2010 Oct; 9(10):1283-7. PubMed ID: 20941956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of coexistent psoriasis and lupus erythematosus.
    Varada S; Gottlieb AB; Merola JF; Saraiya AR; Tintle SJ
    J Am Acad Dermatol; 2015 Feb; 72(2):253-60. PubMed ID: 25486913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infliximab-induced discoid lupus erythematosus.
    Cemil BC; Atas H; Canpolat F; Akca Y; Sasmaz R
    Lupus; 2013 Apr; 22(5):515-8. PubMed ID: 23554040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adalimumab-Induced Cutaneous Lupus Erythematosus in a 16-Year-Old Girl with Juvenile Idiopathic Arthritis.
    West ES; Nanda K; Ofodile O; Rutledge J; Brandling-Bennett HA
    Pediatr Dermatol; 2015; 32(4):e140-4. PubMed ID: 25845414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse cutaneous reactions induced by TNF-alpha antagonist therapy.
    Borrás-Blasco J; Navarro-Ruiz A; Borrás C; Casterá E
    South Med J; 2009 Nov; 102(11):1133-40. PubMed ID: 19864977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced lupus due to anti-tumor necrosis factor alpha agents.
    Costa MF; Said NR; Zimmermann B
    Semin Arthritis Rheum; 2008 Jun; 37(6):381-7. PubMed ID: 17977585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five cases of anti-tumor necrosis factor alpha-induced psoriasis presenting with severe scalp involvement in children.
    Perman MJ; Lovell DJ; Denson LA; Farrell MK; Lucky AW
    Pediatr Dermatol; 2012; 29(4):454-9. PubMed ID: 21995665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: the Mayo Clinic experience, 1998 to 2010.
    Shmidt E; Wetter DA; Ferguson SB; Pittelkow MR
    J Am Acad Dermatol; 2012 Nov; 67(5):e179-85. PubMed ID: 21752492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TNF agents for the treatment of psoriasis.
    Kircik LH; Del Rosso JQ
    J Drugs Dermatol; 2009 Jun; 8(6):546-59. PubMed ID: 19537380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the development of drug-related lupus a contraindication for switching from one TNF alpha inhibitor to another?
    Kocharla L; Mongey AB
    Lupus; 2009 Feb; 18(2):169-71. PubMed ID: 19151120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subacute cutaneous lupus erythematosus in the course of rheumatoid arthritis: a relationship with TNF-α antagonists and rituximab therapy?
    Lis-Święty A; Brzezińska-Wcisło L; Widuchowska M; Kucharz E
    Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):443-6. PubMed ID: 23537059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors.
    Deng A; Harvey V; Sina B; Strobel D; Badros A; Junkins-Hopkins JM; Samuels A; Oghilikhan M; Gaspari A
    Arch Dermatol; 2006 Feb; 142(2):198-202. PubMed ID: 16490847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acneiform eruption following anti-TNF-alpha treatment: a report of three cases.
    Sun G; Wasko CA; Hsu S
    J Drugs Dermatol; 2008 Jan; 7(1):69-71. PubMed ID: 18246701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect?
    Roux CH; Brocq O; Leccia N; Giacchero D; Breuil V; Albert C; Lacour J; Perrin C; Euller-Ziegler L
    J Rheumatol; 2007 Feb; 34(2):434-7. PubMed ID: 17295430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
    Walling HW; Sontheimer RD
    Am J Clin Dermatol; 2009; 10(6):365-81. PubMed ID: 19824738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-TNF-induced lupus.
    Williams EL; Gadola S; Edwards CJ
    Rheumatology (Oxford); 2009 Jul; 48(7):716-20. PubMed ID: 19416947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities.
    Piérard GE; Piérard-Franchimont C; Szepetiuk G; Paquet P; Quatresooz P
    Expert Opin Biol Ther; 2010 Aug; 10(8):1197-208. PubMed ID: 20560729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alopecia areata universalis elicited during treatment with adalimumab.
    Pelivani N; Hassan AS; Braathen LR; Hunger RE; Yawalkar N
    Dermatology; 2008; 216(4):320-3. PubMed ID: 18230980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-TNF-alpha induced psoriasiform eruptions with severe scalp involvement and alopecia: report of five cases and review of the literature.
    Osório F; Magro F; Lisboa C; Lopes S; Macedo G; Bettencourt H; Azevedo F; Magina S
    Dermatology; 2012; 225(2):163-7. PubMed ID: 23052429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis].
    Haake H; Köneke J; Amann K; vom Dahl J; Janssen U
    Med Klin (Munich); 2007 Oct; 102(10):852-7. PubMed ID: 17928969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.